Vimedimex Medi-Pharma JSC (VMD) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

The company has declared Negative results for the last 6 consecutive quarters

NET SALES(Q) At VND 241,273.85 MM has Fallen at -31.95%
OPERATING PROFIT(Q) Lowest at VND 2,590.9 MM
OPERATING PROFIT MARGIN(Q) Lowest at 1.07 %

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

VND 260,941 Million (Micro Cap)

P/E

10.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.99

Return on Equity

7.62%

Price to Book

0.76

Revenue and Profits:

Net Sales:

241,274 Million

(Quarterly Results - Mar 2025)

Net Profit:

3,872 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

0.9%

6 Months

0.6%

1 Year

-0.88%

2 Years

-24.44%

3 Years

-15.33%

4 Years

-56.46%

5 Years

-23.23%

Vimedimex Medi-Pharma JSC for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-42.82%

EBIT Growth (5y)

-61.18%

EBIT to Interest (avg)

4.28

Debt to EBITDA (avg)

0.52

Net Debt to Equity (avg)

-0.97

Sales to Capital Employed (avg)

11.12

Tax Ratio

23.10%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

71.81%

ROE (avg)

7.65%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.74

EV to EBIT

-60.17

EV to EBITDA

-3.15

EV to Capital Employed

-9.53

EV to Sales

-0.07

PEG Ratio

0.24

Dividend Yield

12.27%

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

7.62%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

Bullish

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2025 is -31.95% vs -68.22% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2025 is 39.35% vs -28.50% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "241,273.80",
          "val2": "354,538.00",
          "chgp": "-31.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,590.90",
          "val2": "7,120.40",
          "chgp": "-63.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "14.90",
          "val2": "705.10",
          "chgp": "-97.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,872.20",
          "val2": "2,778.80",
          "chgp": "39.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2.40%",
          "val2": "13.60%",
          "chgp": "-1.60%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -64.73% vs -49.90% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -24.86% vs -15.29% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,249,868.10",
          "val2": "3,543,979.60",
          "chgp": "-64.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "27,631.90",
          "val2": "52,568.50",
          "chgp": "-47.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3,703.00",
          "val2": "1,755.40",
          "chgp": "110.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "241.80",
          "val2": "557.50",
          "chgp": "-56.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "22,375.00",
          "val2": "29,777.60",
          "chgp": "-24.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.40%",
          "val2": "10.70%",
          "chgp": "-0.63%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY

Mar'25

Mar'24

Change(%)

Net Sales

241,273.80

354,538.00

-31.95%

Operating Profit (PBDIT) excl Other Income

2,590.90

7,120.40

-63.61%

Interest

14.90

705.10

-97.89%

Exceptional Items

0.00

Consolidate Net Profit

3,872.20

2,778.80

39.35%

Operating Profit Margin (Excl OI)

-2.40%

13.60%

-1.60%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2025 is -31.95% vs -68.22% in Mar 2024

Consolidated Net Profit

YoY Growth in quarter ended Mar 2025 is 39.35% vs -28.50% in Mar 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

1,249,868.10

3,543,979.60

-64.73%

Operating Profit (PBDIT) excl Other Income

27,631.90

52,568.50

-47.44%

Interest

3,703.00

1,755.40

110.95%

Exceptional Items

241.80

557.50

-56.63%

Consolidate Net Profit

22,375.00

29,777.60

-24.86%

Operating Profit Margin (Excl OI)

4.40%

10.70%

-0.63%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -64.73% vs -49.90% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -24.86% vs -15.29% in Dec 2023

All Annual Results

Company CV

About Vimedimex Medi-Pharma JSC

Vimedimex Medi-Pharma JSC

Pharmaceuticals & Biotechnology

Vimedimex Medi-pharma Joint Stock Company (Vimedimex) is a Vietnam-based company engaged in the distribution of pharmaceutical products. It is involved in the import and export of pharmaceutical products, pharmaceutical materials, laboratory chemicals, medical equipment and functional food. The Company also provides offices, along with general and bonded warehouses for rent. In addition, it cultivates medicinal and herbal plants, as well as researches and manufactures pharmaceutical products and functional tea from those plants.

Company Coordinates

Company Details

246 Cong Quynh, Phuong Pham Ngu Lao, Quan 1 HANOI None : None

Tel: 84 8 3925426484 28 39254264

http://vietpharm.com.vn/

Registrar Details